Airways disease

G. Brusselle (Ghent, Belgium)

Source: Virtual Congress 2020 – Impact in children and in adults with premorbid respiratory disease (acute and long-term)
Disease area: Airway diseases, Paediatric lung diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Brusselle (Ghent, Belgium). Airways disease. Virtual Congress 2020 – Impact in children and in adults with premorbid respiratory disease (acute and long-term)

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Airways diseases I
Source: ERS Course 2015
Year: 2015

Airways diseases I
Source: HERMES Summer School 2014 - Educational material
Year: 2014

Airways diseases II
Source: ERS Course 2015
Year: 2015

Airways diseases II
Source: HERMES Summer School 2014 - Educational material
Year: 2014

CT of the Airways
Source: Eur Respir Rev 2011; 20: 65
Year: 2011


Airways infections in patients with interstitial lung diseases
Source: Annual Congress 2009 - Cell biology of lung disease
Year: 2009


Inflammatory airway diseases and clinical allergy: Inflammatory Airways Diseases and Clinical Allergy Assembly contribution to the celebration of 20 years of the ERS
Source: Eur Respir J 2010; 35: 1197-1199
Year: 2010


Scleroderma lung disease
Source: Eur Respir Rev 2013; 22: 6-19
Year: 2013


Small Airways Disease and Emphysema (Assessed by High-Resolution CT) and Symptom Burden in COPD
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


Late Breaking Abstract - Small Airways Dysfunction (SAD) correlates with relevant asthma outcomes: longitudinal results from the AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS) Study
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020


Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Cardiovascular disease in COPD
Source: Eur Respir Monogr 2020; 88: 47-65
Year: 2020


Role of antibiotics in exacerbations of chronic obstructive pulmonary disease: a Cochrane review
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006


Airways mucus pathogenesis in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018



Asthma and smoking-induced airway disease without spirometric COPD
Source: Eur Respir J, 49 (5) 1602061; 10.1183/13993003.02061-2016
Year: 2017



Chronic obstructive pulmonary disease (COPD) and alterations of hemogram
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014

Clinical factors linked with coronary artery disease in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014

The metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014